Neuphoria Therapeutics (NEUP) Change in Cash (2023 - 2026)
Neuphoria Therapeutics (NEUP) posted quarterly Change in Cash of -$2.8 million for Q1 2026, down 122.12% year-over-year from $12.7 million in Q1 2025, and down 132.97% quarter-over-quarter from $8.5 million in Q4 2025.
Neuphoria Therapeutics (NEUP) Change in Cash (2023 - 2026) Analysis & Trends
Neuphoria Therapeutics (NEUP) has reported Change in Cash for 4 consecutive years, with -$2.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 122.12% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at $2.3 million (down 73.06% YoY), while the FY2025 annual figure was $1.6 million, up 217.18% from the prior year.
- Change in Cash eased to -$2.8 million in Q1 2026 per NEUP's latest filing, from $8.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $12.7 million in Q1 2025 and bottomed at -$4.5 million in Q3 2024.
- Historically, Change in Cash has averaged $659882.8 across 4 years, with a median of -$1.7 million in 2024.
- Annual changes were most pronounced in 2024 — Change in Cash sank 300.16% — and 2025, when it surged 833.07%.
- Neuphoria Therapeutics' Change in Cash stood at $1.9 million in 2023, then slumped by 300.16% to -$3.7 million in 2024, then jumped by 327.47% to $8.5 million in 2025, then sank by 132.97% to -$2.8 million in 2026.
- Business Quant data shows NEUP's Change in Cash at -$2.8 million in Q1 2026, $8.5 million in Q4 2025, and -$560488.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Neuphoria Therapeutics | 21.28 Mn | 1.84 Mn | - | -2.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.81 Mn |
| Dec 31, 2025 | 8.52 Mn |
| Sep 30, 2025 | -560,488.00 |
| Jun 30, 2025 | -2.83 Mn |
| Mar 31, 2025 | 12.70 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Sep 30, 2024 | -4.52 Mn |
| Jun 30, 2024 | 4.18 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | -3.82 Mn |